SCN8A and epilepsy: These findings raise the possibility that aberrant overexpression of Scn8a in limbic structures may be pathogenic in some types of epilepsy, including temporal lobe epilepsy (TLE), thereby pointing to SCN8A as a promising therapeutic target.